Verastem reported $97.88M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
AstraZeneca AZN:LN 20.92B 1.73B
Curis CRIS:US $ 113.4M 12.74M
Cytokinetics CYTK:US $ 602.25M 21.28M
Epizyme EPZM:US $ 186.84M 41.87M
Gilead Sciences GILD:US $ 13705M 1076M
Immunogen IMGN:US $ 373.87M 82.84M
Laboratory Of America LH:US $ 5030.8M 198.7M
Novartis NOVN:VX 38.14B 906M
Verastem VSTM:US $ 97.88M 15.56M
YTE INCY:US $ 3625.84M 337.75M
Ziopharm Oncology ZIOP:US $ 61.36M 8.41M